Green Rush Podcast

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare. Our hosts engage in a fascinating discussion with Sebastian Brunemeier, a true powerhouse in the longevity and regenerative medicine space. Sebastian is a biotech venture capitalist and company builder with a laser focus on extending human health span. As the co-founder and general partner of Healthspan Capital and the CEO and founder of ImmuneAgeBio, Sebastian is at the forefront of immune system rejuvenation research.  Over the past five years, he has co-founded four longevity biotech companies with a combined equity value exceeding $600 million. Sebastian's background includes roles as co-founder and chief investment officer at Cambrian Biopharma, co-founder and COO of Samsara Therapeutics, and principal at Apollo Health Ventures, the world's first and largest aging-focused venture capital fund managing $200 million in assets. Podcast Highlights: Introduction to Sebastian Brunemeier (00:11): Overview of Sebastian's background and his various roles in the longevity biotech space. The Longevity Biotech Landscape (02:36): Discussion of Sebastian's journey into longevity science and his mission to bring capital and talent into the field. Healthspan Capital and Investment Strategy (27:48): Insights into Healthspan Capital's approach to investing in longevity biotech companies. The Global Demographic Aging Crisis (23:25): Exploration of the "silver tsunami" and how longevity science aims to address this global challenge. Cutting-Edge Research in Longevity (39:54): Discussion of promising studies in the longevity space, including blood plasma research and stem cell therapies. The Political and Social Movement of Longevity (45:00): Introduction to the concept of startup cities and the Prospera project as hubs for longevity research and development. Personal Longevity Practices (53:35): Sebastian's insights on personal health protocols and cautionary advice on experimental interventions. Social Media: X: @sebastian_gero LinkedIn: https://www.linkedin.com/in/sebastianlongbio/  Other Links/Mentions/Resources: LongevityList.com: https://longevitylist.com/  Stranded Technologies Podcast interview: https://www.strandedtechnologies.com/p/ep-15-sebastian-a-brunemeier-on-the-9b0  ImmuneAgeBio: https://immuneage.bio/  Healthspan Capital: https://www.healthspancapital.vc/  Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare. Hosts Phil Carlson and Anne Donohoe dive into the world of longevity technology with guest Petr Sramek, a visionary in the field of longevity tech. Petr is the co-founder, chairman, and managing general partner of the Longevitytech.fund, bringing over 33 years of experience as a serial tech entrepreneur to the table. His impressive resume includes being a former entrepreneur-in-residence at Singularity University and co-founder of theLongevityForum.eu. Currently serving on the boards of several cutting-edge companies in the longevity sector, including Animal Biosciences in the U.S. and Age Curve in the U.K., Petr is dedicated to building the scientific, financial, and business infrastructure needed to accelerate the adoption of technologies that improve our health span. Podcast Highlights: Introduction of Petr Sramek (00:11): Overview of Petr's background as co-founder and chairman of the Longevity Tech Fund and his experience in technology entrepreneurship. Concept of "Healthy Longevity" (02:48): Explanation of the focus on expanding the healthy and active part of life rather than just extending the overall lifespan. Longevity Tech Fund Investment Strategy (17:35): Discussion of investment ticket sizes ranging from $100,000 to $600,000 and the fund's approach to selecting companies. Longevity vs Traditional Biotech (29:34): Differentiation between longevity and traditional biotech investments, highlighting that aging is not classified as a disease. CRISPR and Gene Therapy in Longevity (37:33): Examination of CRISPR's current limitations in longevity applications and the potential of gene therapy as a more relevant near-term approach. Advice for Investors and Companies (42:54): Guidance for retail investors interested in the longevity space and information on how companies can pitch to the Longevity Tech Fund. Personal Longevity Practices (47:30): Petr's sharing of his own experiences with longevity interventions, including his epigenetic age results showing a 16-year difference from his chronological age. Social Media: Petr's LinkedIn: https://www.linkedin.com/in/petrsramek/  X: https://x.com/petrsramekbench  Other Links/Mentions/Resources: Longevitytech.fund: https://www.longevitytech.fund/en/home  Longevity Forum EU: https://www.longevityforum.eu/en/home  HealthyLongevity.clinic: https://www.healthylongevity.clinic/  Singularity University: https://www.su.org/  AgeCurve: https://agecurve.co.uk/  Animal Bioscience: https://animalbioscience.com/about-us/  Show Credits: This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare. We sat down with Lou Reese, co-founder and Vice Chairman of Vaxxinity, a purpose-driven biotechnology company pioneering a new class of medicines aimed at disrupting existing treatments for chronic diseases. Founded in 2014 alongside his wife and CEO, Mei Mei Hu, Vaxxinity is at the forefront of developing "next generation" vaccines for chronic conditions such as Alzheimer's, Parkinson's, heart disease, and migraine. Lou Reese also serves on the Executive Committee of United Biomedical, Inc. (UBI), a multinational biopharmaceutical organization focused on developing diagnostics and immunotherapeutics for global health improvement. Lou was a director at ShenLian Biotech, one of the largest animal health companies in China, and co-founded an investment firm with ventures spanning real estate, energy, hospitality, and life sciences. Podcast Highlights: Introduction & Lou Reese's Background (3:00): Lou's journey and his mission to eliminate global suffering. Synthetic Peptide Technology (10:15): Discussion of Vaxxinity's innovative approach to vaccine development. Active Immunotherapy Medicines (18:30): Vaxxinity's work on developing active immunotherapy medicines. Parkinson's Disease Breakthrough (23:45): Promising results from Vaxxinity's Parkinson's trials. Company Restructuring (32:00): Vaxxinity's decision to delist and deregister, and plans for becoming a B Corp. Army of Compassion (41:30): Global prevention trial for Alzheimer's and partnership with former Governor David Beasley. Future of Healthcare (48:45): Lou's vision for affecting billions of lives and revolutionizing healthcare spending. Social Media: Lou Reese's LinkedIn: https://www.linkedin.com/in/lou-reese-6b54504/  X: https://x.com/notloureese  Other Links/Mentions/Resources: Vaxxinity's official website: https://www.vaxxinity.com/  World Food Programme: https://www.wfp.org/  Mayo Clinic: https://www.mayoclinic.org/  UT Health: https://www.uthscsa.edu/  Amprion: https://www.amprionme.com/  United Therapeutics: https://www.unither.com/  Show Credits: This episode was hosted by Lewis Goldberg of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare. We sat down with Dr. Bob Harari, a renowned biomedical scientist, surgeon, and entrepreneur. He is the Founder, Chairman, and CEO of Celularity, a biotechnology company leading the next evolution in cellular medicine. Dr. Hariri pioneered the use of stem cells to treat a range of life-threatening human diseases and continues today to make transformative contributions in the fields of immuno-oncology and cell therapeutics along with tissue engineering and functional regeneration.  Dr. Hariri is widely acknowledged for his discovery of pluripotent stem cells derived from the human placenta, and as a member of the team that discovered the physiological activities of tumor necrosis factor (TNF). He holds over 150 issued and pending patents for discoveries including placenta-derived stem cells, which Nature recognized as one of the ten most important patent estates in the field. Dr. Hariri was the founder and CEO of Anthrogenesis Corporation, and after its acquisition by Celgene Corporation, served as CEO of Celgene Cellular Therapeutics. Dr. Hariri also co-founded the genomic-based health intelligence company, Human Longevity, Inc. Podcast Highlights: Introduction & Dr. Bob Harari's Research (1:00): Dr. Harari's background and journey to longevity science. Placental Stem Cells (04:30): Advantages of using placental-derived stem cells and their ethical considerations. Universal Donor Tissue (10:05): Concept of the placenta as a universal donor tissue is explored, highlighting its potential in cellular therapies. Genetic Modification (12:40): Process of genetic modification in stem cells and their natural intelligence. Chimerism (20:35): The potential therapeutic benefits of chimerism in cellular medicine are discussed. Adult Stem Cell Banking (24:18): Cellularity's adult stem cell banking program and its value for future treatments. Future of Stem Cell Medicine (36:40): A vision of stem cell medicine in 10 years, including potential treatments for cancer, autoimmune diseases, and aging-related conditions. Social Media: Dr. Bob Hariri's Instagram: https://www.instagram.com/drbobhariri/?hl=en  Dr. Bob Hariri's LinkedIn: https://www.linkedin.com/in/bob-hariri-md-phd-3654b239/  Other Links/Mentions/Resources: Cellularity's official website: https://www.cellularity.com/  National Institutes of Health (NIH) information on stem cells: https://stemcells.nih.gov/  FDA resources: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products  Nature article on chimerism: https://www.nature.com/articles/d41586-021-01001-2  The American Society for Gene and Cell Therapy's patient education page: https://asgct.org/education  Show Credits: This episode was hosted by Lewis Goldberg of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare. Our hosts sat down with Dr. Moshe Szyf, a pioneering figure in the field of epigenetics with a career spanning over three and a half decades. A founding figure in behavioral and psychiatric epigenetics, Dr. Szyf has authored over 300 influential papers that have significantly contributed to our understanding of how environmental factors and behaviors can influence gene expression without altering the DNA sequence itself.  Dr. Szyf serves as Chairman, CEO, and Chief Scientific Officer of HKG Epitherapeutics, focusing on developing epigenetic tools for clinical medicine, early disease detection, and personalized healthcare. He also currently holds the prestigious position of James McGill Professor of Pharmacology and Therapeutics at McGill University in Montreal, where he also holds the GlaxoSmithKline Chair in Pharmacology.  Podcast Highlights: Introduction to Epigenetics (00:11 - 02:37): Dr. Moshe Szyf is introduced as a pioneer in epigenetics. The concept of epigenetics is explained as the "software" that programs DNA, influencing how genes function without changing the DNA sequence itself. HKG Epitherapeutics and Epigenetic Testing (02:38 - 06:05): Discussion of Dr. Szyf's company, HKG Epitherapeutics, which develops epigenetic tests for early disease detection, aging assessment, and health monitoring. Epigenetics vs. Traditional Testing (06:06 - 09:44): Explanation of how epigenetic testing differs from traditional blood tests and genetic testing, offering insights into the dynamic changes happening at the DNA level. Consumer Impact and Health Empowerment (09:45 - 14:42): Examples of how consumers have used epigenetic tests to gain insights into their biological age and health status, leading to lifestyle changes. COVID-19's Impact on Healthcare Autonomy (29:38 - 33:40): Discussion on how the pandemic has led to increased public interest in personal health management and a shift towards more patient autonomy in healthcare decisions. Future of Precision Medicine (39:12 - 42:06): Dr. Szyf's views on the role of epigenetics in precision medicine, particularly in guiding personalized drug treatments and lifestyle interventions. Ethical Considerations and Balanced Approach to Longevity (34:55 - 39:11): Dr. Szyf's perspective on extreme anti-aging approaches, emphasizing the importance of balance and quality of life over extreme life extension methods. Future Developments in Epigenetics (43:25 - 45:37): Discussion of anticipated breakthroughs in epigenetic technology, including improved accuracy in testing and applications for early detection of various chronic diseases. Social Media: LinkedIn https://www.linkedin.com/in/moshe-szyf-99ab283/?originalSubdomain=ca  @epimedtech https://twitter.com/epimedtech  Other Links/Mentions/Resources: EpiMedTechGlobal https://epimedtech.com/  Dr. Szyf's Ted Talk https://www.ted.com/talks/moshe_szyf_how_early_life_experience_is_written_into_dna?subtitle=en  CDC Resources for Epigenetics https://www.cdc.gov/genomics-and-health/about/epigenetic-impacts-on-health.html  Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare. We met with Dr. Nir Barzilai, director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity.  Treatments for age-related diseases like type 2 diabetes are being developed based on Dr. Barzilai's work and are currently in clinical trials. In addition to his “longevity gene” research, Dr. Barzilai studies key mechanisms involved in the biology of aging, including how nutrients and genetics influence lifespan. He is also investigating the physical and mental declines associated with aging and how they affect longevity. Dr. Barzilai is professor of medicine (endocrinology) and of genetics, a member of the Diabetes Research Center, and director of the Diabetes Research and Training Center's Animal Physiology core. Podcast Highlights: Introduction & Dr. Nir Barzilai's Groundbreaking Discovery (00:00 - 03:15): Overview of Dr. Nir Barzilai's discovery of the first “longevity gene” in humans and its link to healthy aging. Discussion on the significance of high HDL cholesterol and how it relates to extreme longevity. The Science Behind Longevity Genes (03:16 - 08:32): Dive into the specific genetic markers that contribute to longevity. Dr. Barzilai shares insights on the mechanisms of aging and the potential to delay or reverse age-related diseases. Current Clinical Trials on Age-Related Diseases (08:33 - 12:10): An exploration of the treatments for type 2 diabetes and other age-related conditions that are being developed from Dr. Barzilai's research, with an update on the progress of these clinical trials. Nutritional and Genetic Influence on Lifespan (12:11 - 17:48): How both genetics and nutrition shape our healthspan and longevity. Dr. Barzilai explains the latest findings on how diet can influence aging and the role of genetics in extending life. Mental and Physical Decline in Aging (17:49 - 21:22): Discussion on the common declines in physical and mental health with aging, and how they impact longevity. Dr. Barzilai talks about ongoing research into mitigating these declines. Future of Longevity Research (21:23 - 26:55): Dr. Barzilai shares his vision for the future of aging research, focusing on potential breakthroughs in longevity science. Social Media: @NirBarzilaiMD: https://x.com/nirbarzilaimd?lang=en  https://www.linkedin.com/in/nir-barzilai-7a86a7212/  Other Links/Mentions/Resources: Age Later by Nir Barzilai, M.D. https://us.macmillan.com/books/9781250230867/agelater  Albert Einstein College of Medicine https://einsteinmed.edu/faculty/484/nir-barzilai  American Federation for Aging Research (AFAR) https://www.afar.org/ Aging is a Treatable Condition - Worth.com The 4 most promising anti-aging drugs investors are sleeping on, according to a leading longevity researcher - Business Insider What is your Biological Age? - The New York Times Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com.

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special episode featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare.  Our host sat down with Dr. Peter Diamandis, a visionary at the forefront of the longevity revolution. Named by Fortune as one of the “World's 50 Greatest Leaders,” Diamandis has started over 20 companies in the areas of longevity, space, venture capital, and education.  Diamandis is the founder & executive chairman of the XPRIZE Foundation, which leads the world in designing & operating large-scale incentive competitions. He is also the co-founder and vice-chairman of Human Longevity Inc., merging advanced genomic sequencing with AI to develop therapies aimed at slowing down or even reversing aging. Additionally, Diamandis co-founded Fountain Life with Tony Robbins, a unique concierge healthcare company dedicated to revolutionizing the healthcare industry. Diamandis is the creator of Abundance360, a year-round program for entrepreneurs, investors, and executives focused on leveraging technology to drive positive change and leave a legacy. Podcast Highlights: Introduction & Dr. Diamandis' Motivations (4:01): Discussion of Diamandis' reasons for focusing on longevity, including its potential as a gift to humanity and a major business opportunity. Envisioning Extended Lifespans (6:55): Exploration of how life might change with significantly extended lifespans and Diamandis' personal perspective on living to 150 or beyond. Ethical Considerations of Longevity (10:24): Addressing concerns about overpopulation and resource depletion, with Diamandis' optimistic view on technological solutions. Breakthrough Technologies in Longevity (15:58): Overview of AI's potential role in understanding aging and discussion of the $101 million XPRIZE Healthspan. Fountain Life and Preventative Diagnostics (23:25): Introduction to Fountain Life's comprehensive health assessment approach and statistics on early disease detection. Personal Health Practices (35:56): Diamandis' approach to diet, exercise, and supplements, with emphasis on reducing sugar intake and increasing vegetable consumption. Investment in Longevity Science (38:28): Advice for potential investors in the longevity space and discussion of challenges in biotech investments. Singularity and AI (42:24): Explanation of Ray Kurzweil's concept of the “singularity” and Diamandis' perspective on the rapid advancement of AI. Guest Social Media: LinkedIn: https://www.linkedin.com/in/peterdiamandis/ X: @PeterDiamandis Other Links/Mentions/Resources: Peter Diamandis Website: https://www.diamandis.com/  Books by Peter Diamandis: https://www.diamandis.com/books  Human Longevity Inc.: https://www.humanlongevity.com/  XPRIZE Foundation: https://www.xprize.org/  Fountain Life: https://www.fountainlife.com/  Singularity University: https://su.org/  Abundance360: https://www.abundance360.com/summit  All affiliated companies and foundations: https://www.diamandis.com/companies  Show Credits: This episode was hosted by Lewis Goldberg of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today our hosts sat down with John Mueller, veteran cannabis entrepreneur and CEO of Greenlight Dispensary. Greenlight is a vertically integrated multi-state operator with more than 30 dispensaries, 3 in-house brands, and more than 750 employees across Missouri, Ohio, West Virginia, Illinois, Nevada, and South Dakota. John is an expert in navigating the complexities of limited license markets and running a debt-free, profitable organization. John has extensive experience in all areas of cannabis cultivation, manufacturing, dispensing, and retail. Prior to founding Greenlight in 2019, he served as Co-Founder and CEO of Acres Cannabis, successfully building and selling operations to Curaleaf, which included a 19,000 sqft experiential dispensary and over 300,000 sqft of cultivation. Under John's leadership, Greenlight issued the first known consecutive dividends by a private cannabis MSO, each totaling over seven figures. John also created “The Underground” and “Greenlight Garage” the world's first-ever cannabis farmers markets where vendors and consumers can directly interact.  So don't sit back, lean forward and enjoy! Social Media: John's LinkedIn: https://www.linkedin.com/in/john-mueller-6a3749a/  Greenlight's LinkedIn: https://www.linkedin.com/company/greenlightdispensary/  Greenlight's X: https://x.com/greenlightdispo  Other Links/Mentions: Greenlight's website: https://greenlightdispensary.com/ Greenlight Ohio: https://greenlightdispensary.com/wintersville/  Nebraskans for Medical Marijuana: https://nebraskamarijuana.org/ Show Credits: This episode was hosted by Anne Donohoe and Maria Petsanas of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we sat down with returning guest Adam Smith, Founder and President of Alliance for Sensible Markets to discuss the news that Vice President Kamala Harris will be rolling out her plan for cannabis legalization. Adam is a longtime activist in the industry, primarily working behind the scenes to develop, draft, and lobby for the passage of cannabis bills at both the state and federal levels. Adam conceptualized, co-wrote, and championed Oregon's landmark 2019 interstate commerce law (on which the 2023 Washington law was also based) and helped write and advocated for California's 2022 interstate law. His expertise and influence have been instrumental in shaping the legal landscape of cannabis in the United States. During our conversation, Adam will share his unique insights on Vice President Harris's upcoming legalization plan, analyzing its potential impact on the industry, the economy, and society at large. We'll explore the intricate details of the proposal, discuss possible challenges and opportunities, and examine how this federal initiative might interact with existing state laws. So don't sit back, lean forward and enjoy! Social Media: LinkedIn: https://www.linkedin.com/in/thatadamsmith/  Other Links/Mentions: Alliance for Sensible Markets: https://www.sensiblemarkets.org/  Marijuana Moment article https://www.marijuanamoment.net/kamala-harris-rolls-out-marijuana-legalization-plan-pledging-to-make-it-the-law-of-the-land/  Show Credits: This episode was hosted by Anne Donohoe and Lewis Goldberg (who still has a bet with Adam!) of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, we have a special edition of the Green Rush featuring our newest production, Alternatively Speaking. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare.  Our hosts sat down with Alternatively Speaking's first-ever guest, Jamie Justice, Executive Vice President of the Health Domain at XPRIZE Foundation and Adjunct Professor in Internal Medicine Section on Gerontology and Geriatric Medicine, and Sticht Center on Healthy Aging and Alzheimer's Prevention at Wake Forest University School of Medicine (WFUSM). Jamie is dedicated to Geroscience research that advances the hypothesis that by targeting the basic biology of aging the incidence of multiple age-related diseases can be delayed or prevented. So don't sit back, lean forward and enjoy! Podcast Highlights: Introduction & XPRIZE Foundation Origins (00:00 - 02:29): Overview of the longevity industry, the impact of the Ansari XPRIZE on private space travel, and XPRIZE's influence on companies like SpaceX. Jamie Justice's Background & Passion for Research (02:30 - 06:14): Jamie's journey into gerontology, early research experiences with older adults, and her focus on empathy and the human aspect of aging. Exploring Aging & Longevity (06:15 - 10:21): Discussion on the fundamental questions of aging, how different interventions (lifestyle, supplements, drugs) impact human health and longevity. Translating Aging Research into Practice (10:22 - 13:10): Jamie's work at Wake Forest, ongoing efforts to apply aging research in real-world settings, and the philosophical aspects of aging—living fully versus focusing on death. Healthspan vs. Lifespan & Longevity Goals (13:11 - 20:43): Exploring the concept of the ‘longevity dividend,' aligning biological health with extended life, and the strategies to improve healthspan by optimizing current biology. XPRIZE HealthSPAN Award & Future of Aging Research (20:44 - 28:28): Introduction to the XPRIZE HealthSPAN Award program, the bold scientific goals it supports, challenges in aging research, and the collaborative efforts to advance the field. Social Media: X: @j_n_justice LinkedIn: https://www.linkedin.com/in/jamie-justice-ph-d-6b933146/  Other Links/Mentions: https://www.xprize.org/  https://www.xprize.org/prizes/healthspan  Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, our hosts sat down with Jhavid Mohseni, CEO of Aperon Corporation. Jhavid's 27-year career spans multiple industries. In 2016, he founded Tamerlane Trading, which became the world's leading quality-verified marketplace for bulk wholesale cannabis. He spearheaded the establishment of the International Cannabis and Hemp Standards (ICHS) to promote trust and transparency in the cannabis supply chain. Jhavid's venture Big Tree Grading implemented ICHS standards, significantly improving cannabis quality grading. In 2023, Jhavid co-founded Cannafax, an AI-enabled platform for qualitative grading and appraisal creating efficiencies in the global cannabis trade.  So don't sit back, lean forward and enjoy! Guest's Social Media: Jhavid's LinkedIn: https://www.linkedin.com/in/jhavidmohseni  Jhavid's Twitter: https://x.com/jhavid_mohseni  Aperon's LinkedIn: https://www.linkedin.com/company/aperon-corporation  Links / Mentions: Aperon Corp https://aperoncorp.com/    Tamerland Trading Co. https://tamerlane.com/  International Cannabis and Hemp Standards (ICHS) https://www.ichstandards.org  Cannafax https://www.cannafax.com/  Show Credits: This episode was hosted by Lewis Goldberg, Phil Carlson, and Maria Petsanas of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. Today, our hosts sat down with George Jage, Co-Founder and CEO of Jage Media, the driving force behind MJ Unpacked, the acclaimed cannabis trade event tailored exclusively for retail and brand executives. Since 2019, George and his team have been dedicated to fostering community within the cannabis industry through dynamic business media and events. His previous roles include serving as President of Marijuana Business Daily and CEO of DOPE Magazine. Recognized for his contributions, George has received prestigious awards such as the Nevada Entrepreneur Award and the Jerry Valen Award of Distinction. Through initiatives like MJ Unpacked, George continues to enhance the cannabis industry by facilitating valuable networking opportunities and promoting growth and collaboration. As a reminder, the next MJ Unpacked events are on Nov. 5 - 7, 2024, Union Station Hotel, St. Louis, MO and Apr. 29 - May 1, 2025, Hard Rock Hotel, Atlantic City, NJ So don't sit back, lean forward and enjoy! Links to guest's social media: LinkedIn: https://www.linkedin.com/in/georgejage/  Twitter: https://twitter.com/georgejage  Links and Mentions: MJ Unpacked: https://mjunpacked.com/  Jage Media: https://jagemedia.com/  World Tea Expo: https://www.worldteaexpo.com/  MJBizDaily: https://mjbizdaily.com/  MJBizCon: https://mjbizconference.com/  Dope Magazine: https://dopemagazine.com/  Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/ Check out our new podcast, Alternatively Speaking. The first 10-episode series dives into the world of longevity, exploring the advancements and challenges surrounding the pursuit of living longer, healthier lives. https://altspeaking.com/ 

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Strategic Communications. This week, we sat down with Luna Stower, Head of Impact at Ispire Technology. Luna is an industry veteran who has passionately advocated for cannabis legalization and social equity. At Ispire, she is at the forefront of efforts to drive positive social change through the development and distribution of cutting-edge vaping technologies. Luna's leadership in advocacy, education, and technology has made her a prominent voice in the industry, and we're thrilled to have her join Green Rush. So don't sit back, lean forward and enjoy! Links and Social Media: Luna's LinkedIn: https://www.linkedin.com/in/lunastower/  Luna's X: https://twitter.com/lunastower Luna's Website: https://www.lunastower.com/  Ispire Website: https://ispiretechnology.com/ Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

The Green Rush team is revisiting our extensive archives, curating a selection of over 300 past episodes. This collection will feature memorable moments, insightful interviews, and some of the team's favorite episodes, providing both new listeners and long-time fans an opportunity to explore or rediscover the best of Green Rush.  Back in 2020, we sat down with Javier Hasse, one of the leading voices in the cannabis industry about the cannabis news of the day including how cannabis companies are responding to the Black Lives Matter movement against police brutality, the launch of his Spanish language news site El Planteo, the role of women in the industry and his favorite stories to tell about his time working in the cannabis industry. With a well-earned reputation as one of the most dutiful and diligent reporters covering the cannabis space, Javier is in the elite tier of media that is a must-follow for anyone interested in the cannabis industry. So don't sit back, lean forward and enjoy! Links to guest's social media: @JavierHasse https://x.com/javierhasse?lang=en  LinkedIn https://www.linkedin.com/in/javierhasse/?locale=en_US  Links and Mentions: El Planteo https://elplanteo.com/  Javier's work on Benzinga https://www.benzinga.com/author/javier-hasse  Javier's work on Forbes https://www.forbes.com/sites/javierhasse/  Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther and Executive Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/ 

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Podcast Labs. This week, we sat down with Hirsh Jain, Founder of Ananda Strategy. Ananda Strategy is a strategy consultancy advising leading cannabis brands, retailers, technology businesses, and venture capital funds across the United States, Canada, and Western Europe. Ananda Strategy represents many of California's leading cannabis retailers, helping lead their expansion strategy, competitive licensing efforts, and M&A activity. Ananda also serves operators in the Arizona, Colorado, Louisiana, Maryland, Massachusetts, Michigan, Nevada, New York, Ohio, and Oregon markets, as well as operators in Canada and Western Europe. Hirsh is Vice Chair of the Cannabis Chamber of Commerce and serves on the boards of NORML California as well as SC Labs, a leading cannabis testing company. He previously held leadership roles at Caliva and MedMen, and worked as the Global Policy Lead at Airbnb, managing public policy in key markets worldwide. Before that, Hirsh was with McKinsey & Company in their Public Sector Practice. Hirsh holds a B.A. in Philosophy from UC Berkeley and a J.D. from Harvard Law School. He has a deep commitment to cannabis law reform, having studied the impacts of the War on Drugs. Social Media: https://www.instagram.com/anandastrategy/ https://twitter.com/anandastrategy  https://www.linkedin.com/in/hirsh-jain-b896b080/  Other Links/Mentions: Ananda Strategy - https://www.anandastrategy.com/ Ohio adult-use cannabis - https://spectrumnews1.com/oh/columbus/news/2024/08/21/adult-use-recreational-marijuana-sales-surge-across-ohio Nebraskans for Medical Marijuana, Crista Egger - https://greenrushpodcast.com/crista-eggers-nebraskans-for-medical-marijuana/  Show Credits: This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas. Check out our new podcast Alternatively Speaking where our hosts dive into the advancements and challenges surrounding the pursuit of living longer, healthier lives in our first 10-episode series. Visit https://altspeaking.com. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/ 

This summer, the Green Rush team is revisiting our extensive archives, curating a selection of over 300 past episodes. This collection will feature memorable moments, insightful interviews, and some of the team's favorite episodes, providing both new listeners and long-time fans an opportunity to explore or rediscover the best of Green Rush. Stay tuned for the upcoming launch of our new podcast in the fall, "Alternatively Speaking." We're revisiting our interview with Jim Belushi, actor, musician, comedian, all around entertainer as well as cannabis entrepreneur and the founder of Belushi's Farms. Jim has long been a household name due to his distinguished acting career but he's also incredibly active in the cannabis community with a nearly 100 acre farm in the heart of Oregon's beautiful banana belt, he is out there getting his hands dirty and producing some of the most-talked about cannabis in the state. With brands like Captain Jack, The Blues Brothers and Good Ugly Weed and Belushi's Secret Stash, Jim Belushi's cannabis products are quickly becoming the most talked about product line across the state. Jim was gracious enough to sit down with our hot Anne Donohoe and guest host Phil Carlson to talk about his cannabis journey and venture into becoming a cannpreneur. In the discussion, Jim dishes on the role cannabis plays in his life, his work with important advocacy organizations like the Last Prisoner Project and why he loves getting into the dirt and actually taking part in the growing of his own plants. This episode was a real treat and something that we hope all of our listeners can enjoy – we sure did! So don't sit back, lean forward and enjoy! Jim Belushi, Hollywood Star and Cannabis Entrepreneur It's been 12 years since Jim first came to Oregon's Rogue Valley where his dear friend John has a sprawling property along the Rogue River, one town over in Shady Cove. Their children are the same age and attended classes together in California, so the families gathered for many activities over the years. With Jim's own family's experience and numerous others marred by opioids and the stigmatization of cannabis, Jim was incredibly grateful to have been led to the Rogue River where he first envisioned Belushi's Farm and his own part in the agricultural and healing gift of cannabis. A proud Chicagoan, Jim graduated from Southern Illinois University with a degree in Speech, Education and Theatre before moving on to become a resident member of Chicago's famed Second City for three years. In 1979, he left for Los Angeles, where he was cast on TV, launching his career as a performer. In addition to starring in a diverse and remarkable list of television and film— movies from Trading Places to Wonder Wheel, working with famed directors like Oliver Stone, Roman Polanski, David Lynch and Michael Mann—Jim wrote and appeared in Saturday Night Live for two seasons. He's also served as an executive producer, music composer, director, book author, and Broadway star. His own television show According to Jim aired for 182 episodes during eight seasons before the family favorite launched into off-net syndication in 2007. Locally, Jim is actively engaged in several projects benefiting the communities surrounding Belushi's Farm in Jackson County, Oregon. In Medford, Jim is helping reconstruct the historic Holly Theater to bring the 1930s Spanish Colonial movie palace back to life as Southern Oregon's largest indoor concert venue. In Eagle Point, Jim's assisting with the reconstruction of The Butte Creek Mill, destroyed in a 2016 electrical fire, to preserve its heritage, build community, and improve the environment. In Los Angeles, Jim's a benefactor of the Greater Los Angeles Veterans Administration, and Stuart House, a program of the Santa Monica-UCLA Medical Center Rape Treatment Center. Jim's also a supporter of The Joyful Heart Foundation in New York City, whose mission is transforming society's response to se...

Welcome to the Green Rush, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture, produced by KCSA Strategic Communications. This week, we sat down with Tyler Beuerlein. Tyler is Chief Strategic Business Development Officer of Safe Harbor Financial, leveraging his extensive experience in building brands, managing key relationships, and strategic partnerships. Tyler has been at the forefront of the cannabis industry for over eight years and touches Financial Institutions, Government Officials, Regulatory Bodies, and the State Legal Cannabis industry.  Prior to working at Safe Harbor, Tyler served as the Chief Revenue Officer and Chief Business Development Officer for Hypur Ventures and is the former Chairman of the National Cannabis Industry Association Banking and Financial Services Committee. Additionally, Tyler was appointed to serve on both the Marijuana Business Daily's Advisory Board and ATACH Cannabis Beverage Council and is also a member of the Forbes Business Development Council. Formerly, Beuerlein founded and managed a large beverage company and was a professional athlete in the New York Mets organization. Social Media: https://www.linkedin.com/in/tyler-beuerlein/ Other Links/Mentions: https://shfinancial.org/ Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/ 

Andrew has been closely following the efforts of organizations like MAPS (Multidisciplinary Association for Psychedelic Studies) and Lykos Therapeutics as they pioneer the use of MDMA-assisted therapy for treating PTSD. Recently, the FDA delivered a surprising and disappointing decision, declining to approve MDMA-assisted therapy despite promising clinical data and asking the company to conduct an additional Phase 3 Study. This ruling has sent shockwaves through the field of psychedelic medicine, especially for those who had high hopes that MDMA would become the first federally regulated psychedelic treatment. In our conversation today, Andrew will share his insights on the FDA's decision, the implications for Lykos Therapeutics, and what this means for the future of psychedelic therapies. We'll delve into the challenges faced by Lykos, including the FDA's request for an additional clinical trial, which could add years and significant costs to the approval process. We'll also explore the broader context of this decision—how it affects the momentum of the psychedelic medicine movement, the reaction from supporters and critics alike, and the potential shifts in strategy as the industry continues to navigate regulatory hurdles. For those interested in the intersection of health, science, and business, this discussion promises to be both timely and insightful. So, without further ado, let's dive into our conversation with Andrew Jacobs. Link to Andrew's New York Times bio: https://www.nytimes.com/by/andrew-jacobs Social Media: X: @AndrewJacobsNYT Other Links/Mentions: F.D.A. Declines to Approve MDMA Therapy, Seeking More Study What Is MDMA Therapy and What Are Its Risks? A Psychedelics Reporter With a Changing Perspective Show Credits: This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/

This summer, the Green Rush team is revisiting our extensive archives, curating a selection of over 300 past episodes. This collection will feature memorable moments, insightful interviews, and some of the team's favorite episodes, providing both new listeners and long-time fans an opportunity to explore or rediscover the best of Green Rush. Stay tuned for the upcoming launch of our new podcast in the fall, "Alternatively Speaking." This week our host Anne Donohoe is joined by the incomparable Betty Aldworth, Director of Communications and Marketing for MAPS. An activist and advocate since her first anti-nukes demonstration as a pre-teen, Betty has spent the last two decades as one of the leading voices around restorative justice and drug policy reform advocating for safety, justice and education within the cannabis and psychedelics industries. In this conversation Anne sat down with Betty to discuss why advocacy for marginalized groups is a core part of who she is, the important intersection of marketing and messaging that shapes these industries, what types of reform she would implement if she were Biden's Drug Czar and what's coming down the pipeline at MAPS. And as a special treat, this discussion included our first ever surprise call-in where a special guest phoned into our recording to ask Betty some additional questions about her work! So sit back and enjoy our conversation with Betty Aldworth, Director of Communications and Marketing at MAPS. Links and mentions in the show: https://maps.org/ https://psychedelicscience.org/  Links to the guest's company and social media accounts: Betty Aldworth's LinkedIn: https://www.linkedin.com/in/bettyaldworth/ Betty Aldworth's Website: https://bettyaldworth.com/ Betty Aldworth's Instagram: https://www.instagram.com/bettyaldworth/  Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther and Producer, Maria Petsanas. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/ 

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. This week, we're back with a new special episode featuring Crista Eggers, a Nebraska Medical Cannabis Advocate and Ballot Initiative Campaign Manager, who has been passionately fighting for over five years for access to medical cannabis in Nebraska. Crista was the driving force behind the successful statewide effort to place a pair of statutory medical cannabis initiatives on the November 2024 ballot. So don't sit back, lean forward, and enjoy! Social Media: LinkedIn: https://www.linkedin.com/in/crista-eggers-142547221/  Other Links/Mentions: Nebraskans for Medical Marijuana website: https://nebraskamarijuana.org/ Donate: https://secure.actblue.com/donate/nemj Shop: https://www.bonfire.com/store/nebraskamarijuana/ Show Credits: This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/  

This summer, we are revisiting our extensive archives, curating a selection from over 300 past episodes. This collection will feature memorable moments, insightful interviews, and some of the team's favorite episodes, providing new listeners and long-time fans an opportunity to explore or rediscover the best of  Green Rush. Stay tuned for the upcoming launch of our new podcast in the fall, "Alternatively Speaking." This week, we're bringing back our conversation with Emmy-winning Writer, Producer, and Director Donick Cary. Well known in the television and film industry for his work on shows like The David Letterman Show, The Simpsons, Silicon Valley, and Parks and Recreation, Donick is also the writer and director of the Netflix hit, Have a Good Trip. This documentary mixes comedy with a thorough investigation of psychedelics, exploring the pros, cons, science, history, future, pop cultural impact, and cosmic possibilities of hallucinogens. It also includes some of the best psychedelic trip stories from celebrities like Sting, Sarah Silverman, Ben Stiller, A$AP Rocky, and the late greats Carrie Fisher and Anthony Bourdain. Our host Lewis sat down with Donick to discuss his film in greater depth, including what drew his attention to psychedelics, his inspiration for developing a documentary around stories of psychedelic trips (and how he sold that idea to Netflix), his own introduction to psychedelics, and whether he's turned to psychedelics to help deal with the anxiety caused by the COVID-19 pandemic. Donick is one of the most talented writers in Hollywood, and it was a real treat to have him join us to discuss his journey. So don't sit back, lean forward, and enjoy! About Filmmaker and Writer Donick Cary: Emmy-winning Writer, Producer, and Director Donick Cary got his start writing for Late Night with David Letterman. He continued writing for Dave at The Academy Awards (but not the Oprah-Uma joke) and served as both Head Writer and "The Guy in the Bear Suit" on Late Show with David Letterman. After five years in late night, Cary moved to The Simpsons, where he served as a Co-Executive Producer for seasons seven through eleven, winning an Emmy and penning many memorable episodes including “D'oh-in in The Wind,” “In Marge We Trust” (Mr. Sparkle), and “Hell Toupee” (Homer gets the hair transplants of a killer). Social Media: Donick's IMDb: https://www.imdb.com/name/nm0142620/ Donick's LinkedIn: https://www.linkedin.com/in/donick-cary-3802439/ Donick's Twitter: https://twitter.com/Donick Donick's Instagram: https://www.instagram.com/donickcary/ Donick's website: https://donickcary.com/ Other Links/Mentions: Have a Good Trip: https://www.netflix.com/title/80231917 Good Trip Merch: https://www.haveagoodtrip.shop/ Show Credits: This episode was hosted by Lewis Goldberg of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/ 

Overview: In this episode of The Green Rush, Anne Donohoe and Lewis Goldberg sit down with Jarrett Annenberg, Senior Vice President and Head of Investments at NewLake Capital Partners, to explore the complexities and opportunities in cannabis real estate. Jarrett shares insights into the challenges and strategies of navigating the cannabis industry, the impact of the potential rescheduling of cannabis, and the future of cannabis real estate investments. NewLake Capital Partners (OTCQX: NLCP) is an internally managed real estate investment trust (REIT) that has invested and committed about $445 million in capital to state-licensed cannabis operators across 12 states. As co-founder of NewLake, Jarrett spearheads portfolio management, capital raising, and overall operations for the company's 32 properties spanning 1.7 million square feet. NewLake Links and Socials: NewLake's LinkedIn: https://www.linkedin.com/company/newlake/  NewLake's X: https://twitter.com/NewLakeCapital Jarrett's LinkedIn: https://www.linkedin.com/in/jarrett-annenberg-8584474/ --- Show Credits: This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: https://www.linkedin.com/company/kcsapodcastlabs/  ---  Show Notes: Introduction to Jarrett Annenberg and NewLake Capital Partners (01:36 - 03:03) Jarrett Annenberg discusses his background in real estate and how he joined NewLake Capital Partners. Overview of NewLake Capital Partners' focus on cannabis real estate through sale-leaseback transactions. Challenges in Cannabis Real Estate (09:20 - 10:08) The difficulties faced by cannabis businesses due to federal illegality and its impact on funding and operations. Comparison between cannabis real estate and other real estate sectors. Impact of Potential Rescheduling of Cannabis (16:56 - 18:15) Discussion on how the rescheduling of cannabis to Schedule III could positively affect NewLake's business. Improvements in tenant credit quality and cash flow as a result of changes in tax laws. The Future of Cannabis Real Estate (19:10 - 21:09) Jarrett explains NewLake's conservative underwriting approach and focus on long-term growth. Anticipated changes and opportunities in the cannabis real estate market. State-Specific Opportunities and Challenges (32:01 - 33:36) Analysis of various states' cannabis markets, highlighting successful and challenging markets. Factors contributing to the success of states like Missouri and the difficulties faced in states like New York. Public vs. Private Cannabis Companies (36:01 - 37:36) Pros and cons of public versus private cannabis companies. Jarrett's perspective on who will dominate the market in the future. Closing Remarks and Future Prospects (42:13 - 43:19) Jarrett shares his optimism for the future of the cannabis industry and the expected tailwinds. Final thoughts on the importance of institutional and regulatory support for the industry's growth. Key Takeaways: Introduction to Jarrett Annenberg: Insights into Jarrett's background and his role at NewLake Capital Partners. Challenges in Cannabis Real Estate: Exploration of the unique challenges faced by the cannabis real estate sector. Impact of Rescheduling: Potential benefits of cannabis rescheduling on NewLake's business model and tenant stability. Forbes: House Lawmakers Vote To Block Federal Marijuana Rescheduling State-Specific Analysis: Success stories and challenges from different state markets in the cannabis industry. Public vs.

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. This week, Anne Donohoe sat down with James Krouse, CEO of Flower Power Genetics, to talk about how his company is working to preserve and reintroduce the best purebred medicinal cannabis strains into the marketplace. James walked our host through his past 30 years of work including how he has painstakingly researched, collected and preserved original Nevil medical seeds, dating back to the golden age of cannabis in the late 1980s and 1990s. James also touches on the medicinal benefits of these original strains, feedback he's received from the industry and how rescheduling will allow for more research opportunities for his group.  If you are interested in learning more about James or Flower Power, you can follow them across social channels and visit the links found in our show notes.  So, sit back and enjoy our conversation with James Krouse, CEO of Flower Power Genetics.  Links, mentions, and socials: Flower Power Website: https://flowerpowergenetics.com/ James' LinkedIn: https://www.linkedin.com/in/james-krouse-fpg/  Utility Patent Announcement: https://mgmagazine.com/press-releases/flower-power-genetics-secures-pending-utility-patent-for-hybrid-adam/  Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true  

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. This week, Anne Donohoe sat down with Gibran Washington, CEO of ETHOS Cannabis, a medical forward multi-state operator with operations in Pennsylvania, Massachusetts and Ohio.   In today's conversation, Gibran opens up to Anne about his journey from corporate America to cannabis and how life lessons learned at a young age from his mother and father shaped his leadership style. Gibran also shares details about ETHOS' unique relationship with Thomas Jefferson University to study cannabis' effect on various conditions including anxiety, insomnia and depression; his thoughts on the potential benefits of rescheduling; and how ETHOS is preparing for the opening up of Ohio's adult use marketplace.   If you are interested in learning more about Gibran or ETHOS Cannabis, visit the links in our show notes. Also, be sure to follow Gibran and ETHOS across all social platforms. So, sit back and enjoy our conversation with Gibran Washington of ETHOS Cannabis.  Links, mentions, and socials: ETHOS Website: https://ethoscannabis.com/  ETHOS-TJU Research Programs: https://ethoscannabis.com/research/  ETHOS Twitter: https://x.com/Ethos_USA  ETHOS Instagram: https://www.instagram.com/ethos.usa/  ETHOS LinkedIn: https://www.linkedin.com/company/ethos-dispensary/  Gibran's LinkedIn: https://www.linkedin.com/in/gibran-washington-25056482/  Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director, Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true  

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe sits down with Tim Pickett, CEO of KindlyMD, a patient-first healthcare and healthcare data company uniquely integrating traditional primary care with medicinal cannabis. In our conversation, Anne and Tim explore his professional evolution from being a board-certified physician assistant to founding a medical cannabis business in one of the most conservative states in the union in Utah.   Anne and Tim touch on a number of topics including KindlyMD's IPO on the Nasdaq, DEA rescheduling and the company's unique position as the only service provider of its kind that has Medicare, Medicaid and Commercial insurance payer contracts. Tim also gives our listeners insight into the machinations of the Utah cannabis marketplace, how it structurally differs from its neighboring states and how rescheduling or descheduling would potentially impact the market.  If you are interested in learning more about Tim or KindlyMD, visit the links in our show notes. Also, be sure to follow Tim and KindlyMD, across all social platforms. So, sit back and enjoy our conversation with Tim Pickett, CEO of KindlyMD.  Links, mentions, and socials: KindlyMD Website: https://kindlymd.com/   KindlyMD Investors Site: https://investors.kindlymd.com/  Tim Pickett's LinkedIn: https://www.linkedin.com/in/utah/  Utah Marijuana: https://utahmarijuana.org/  KindlyMD Instagram: https://www.instagram.com/kindly.md/  KindlyMD YouTube: https://www.youtube.com/@kindlymd  Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Kris Krane are back to sit down with Paul Armentano, Deputy Director of NORML. Paul joined our hosts this week to talk about his career of advocacy work within the cannabis space and to highlight the positives and shortcomings with the DEA's proposed move to reschedule cannabis. Paul walked us through his thoughts, which can also be found in his recent op-ed in the Orange County Register, as well as what he thinks will move the needle through the DEA open comment period.  Kris and Paul also dive into the debate of incrementalism vs full reform for cannabis as well as why it's critical to ensure advocacy organizations like NORML stay funded and operational, even as the U.S. becomes more accepting of cannabis.   If you are interested in learning more about Paul or how to get more involved in NORML's work, visit the links in our show notes. Also, be sure to follow NORML, as well as the organization's local chapters, across all social platforms. So, sit back and enjoy our conversation with Paul Armentano of NORML. Links, mentions, and socials: NORML Website: https://norml.org/marijuana  NORML Instagram: https://www.instagram.com/natlnorml  NORML News: https://norml.org/subscribe  Paul's Appearance on The Disagreement: https://thedisagreement.substack.com/p/episode-7-marijuana-legalization Paul's review on scientific literature around cannabis and cannabinoids: https://www.amazon.com/Clinical-Applications-Cannabis-Cannabinoids-Scientific-ebook/dp/B09KSTZPDJ NORML on recent medical marijuana research: https://norml.org/marijuana/library/recent-medical-marijuana-research/ Recent bylines from Paul: https://otherwords.org/authors/paul-armentano/  Paul's OC Register byline: https://www.ocregister.com/2024/05/14/the-beginning-of-the-end-of-cannabis-prohibition/  Show Credits: This episode was hosted by Anne Donohoe and Kris Krane of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week we wanted to revisit our conversation with special guest Dr. Hans Eriksson, Chief Medical Officer for HMNC Brain Health. Hans joined us to discuss his role at HMNC, the company's research and development efforts to identify and bring to market treatments for mental health disorders, and the latest news and progress on the psychedelics movement. With the death of the beloved actor Matthew Perry back in the news, we spoke with Hans about illicit ketamine use and how the news about Perry's use was presented by the media, and the risks associated with the treatment. If you are interested in learning more about Hans or to check out the latest updates from HMNC Brain Health, visit the links in our show notes. Also, be sure to follow HMNC and Hans on LinkedIn. So, sit back and enjoy our conversation with Dr. Hans Eriksson of HMNC Brain Health. Links, mentions, and socials: HMNC Brain Health: hmnc-brainhealth.com HMNC Brain Health LinkedIn: de.linkedin.com/company/hmnc-brain-health Dr. Hans Eriksson LinkedIn: linkedin.com/in/hansaeriksson https://www.washingtonpost.com/entertainment/2024/05/22/matthew-perry-death-investigation-ketamine/  Show Credits: This episode was hosted by Nick Opich and Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture. This week's episode is a crossover roundtable event with our friends at the Multidisciplinary Association for Psychedelic Studies (MAPS) covering the DEA's proposed rescheduling of cannabis from Schedule I to a Schedule III drug. Hosted by our very own Anne Donohoe, the Q&A discussion also features Betty Aldworth, Director of Communications & Post-Prohibition Strategy at MAPS, Karen O'Keefe, Director of State Policies at Marijuana Policy Project (MPP) and Paul Armentano, Deputy Director at NORML.  With the unprecedented federal drug policy change on the near horizon, MAPS assembled leaders with more than 50 years of combined experience in the cannabis policy reform movement to talk about what these changes are, why they matter, what myths need debunking, and what still needs to be done. Some of the topics covered in this conversation include the impact rescheduling will have on research and development of cannabis-based medicines, criminal law and systems-impacted people, cannabis banking and interstate commerce and veteran affairs.  If you are interested in learning more about how MAPS, MPP or NORML have played pivotal roles in implementing drug policy reform over the decades, be sure to follow them all on their socials linked in our show notes and visit their websites to follow their advocacy work.   So, sit back and enjoy this crossover Q&A discussion on the future of cannabis drug policy.  Links and mentions in the show https://maps.org/  https://norml.org/  https://www.mpp.org/  Links to the guest's company and social media accounts Betty Aldworth LinkedIn: https://www.linkedin.com/in/bettyaldworth/  Karen O'Keefe LinkedIn: https://www.linkedin.com/in/karen-o-keefe-255a9921a/  NORML LinkedIn: https://www.linkedin.com/company/norml/  MPP Twitter: https://twitter.com/marijuanapolicy  NORML Twitter: https://twitter.com/NORML  MAPS Twitter: https://twitter.com/maps  Show Credits: This episode was hosted by Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther and to the MAPS team.  You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture.  This week Lewis Goldberg and Kris Krane sit down with long-time friend of the podcast Adam Smith, Founder and President of the Alliance for Sensible Markets, to talk about the DEA's historic decision to reclassify cannabis from a Schedule I to Schedule III drug. As a long-time advocate working behind the scenes for decades to reverse the US's draconian cannabis laws, Adam is cautiously optimistic about this development, noting that one of the most exciting changes will be the increase in research opportunities of cannabis for medical use. Adam and our hosts also discuss the potential impacts this development will have on the industry and markets, the elimination of the 280E tax, and the potential global rescheduling of cannabis under the UN Single Convention on Narcotics. As the industry awaits what comes next, the team identifies M&A opportunities and clarity on interstate commerce as key areas of interest to watch over the coming months.  If you are interested in learning more about Adam and how his organization is fighting for a more sustainable legal cannabis industry, visit the links in our show notes and be sure to follow Adam and the Alliance for Sensible Markets on LinkedIn. So, sit back and enjoy our conversation with Adam Smith, Founder of Alliance for Sensible Markets.  Links and mentions in the show https://www.sensiblemarkets.org/  Links to the guest's company and social media accounts Adam Smith LinkedIn: https://www.linkedin.com/in/thatadamsmith/  Alliance for Sensible Markets Twitter: https://twitter.com/statescantwait  Show Credits: This episode was hosted by Lewis Goldberg and Kris Krane of KCSA Strategic Communications. Special thanks to our Program Director, Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets, and culture.  This week hosts Anne and Phil speak with Ian Dominguez, founder and CIO of Delta Emerald Ventures, a leader in intelligent cannabis investing and industry insight. Ian joins Anne and Phil to talk about the booming market in hemp-derived products, including the growing drinks category, industry consolidation, and the conditions that lead him to start up CannaDataCon, a conference focusing on the intersection of legal cannabis and good data strategy. Links, mentions, and socials: Delta Emerald Ventures: https://www.deltaemerald.com/ Ian Dominguez on LinkedIn: https://www.linkedin.com/in/iancdominguez/ CannaDataCon: https://www.cannadatacon.com/ CannaDataCon on LinkedIn: https://www.linkedin.com/company/88961565 CannaDataCon on YouTube: https://www.youtube.com/channel/UCrkQ85bVUImGUrY3ZXIJFhg To learn more about CannaDataCon, check out Ian's welcome remarks. And to go deeper into hemp beverages, check out Delta Emerald's view on the category and hear how leading brands describe the regulatory environment.   Show Credits: This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: Twitter: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Lewis Goldberg is back for a revisited episode with special guest Ric Flair, Hall-of-Fame wrestler and Founder of Ric Flair Drip, a cannabis brand that offers flower, pre-rolls, edibles and more. Ric joins us this week to discuss his wrestling experiences and perspective on the industry, the parallels of wrestling and cannabis, and his product line Ric Flair Drip, plus a few special questions from fans. If you are interested in learning more about Ric Flair Drip, head to the links in our show notes. Also, be sure to follow Ric Flair and Ric Flair Drip on Instagram and Twitter to see what he's up to and to learn more about his great products. So sit back and enjoy our conversation with the Nature Boy, himself.  Links and mentions in the show https://ricflairdrip.com/  https://www.natureboyricflair.com/  https://carmahold.com/  Links to the guest's company and social media accounts Ric Flair Drip Instagram: https://www.instagram.com/ricflairdrip/  Ric Flair Drip Twitter: https://twitter.com/_RicFlairDrip  Ric Flair's Instagram: https://www.instagram.com/ricflairnatureboy/  Ric Flair's Twitter: https://twitter.com/RicFlairNatrBoy  Show Credits: This episode was hosted by Lewis Goldberg of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: Twitter: @The_GreenRush  Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/  Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Phil Carlson and Anne Donohoe talk to Socrates Rosenfeld, CEO and Co-Founder of Jane Technologies. Socrates joins us to discuss his experience in the US Army, having never touched cannabis, and the journey which led to the birth of Jane Technologies and its unique vision on how consumers want to shop. In this episode, Socrates describes to our hosts his first experience with cannabis and shares his many accomplishments, both personally and professionally, including the innovative solutions Jane offers to brands and retailers as well as consumers. If you are interested in learning more about Socrates and the latest out of Jane Technologies, visit the links in our show notes. Also, be sure to follow Jane and Socrates on LinkedIn. So, sit back and enjoy our conversation with Socrates Rosenfeld, CEO and Co-Founder of Jane Technologies. Links, mentions, and socials: Jane Technologies: https://www.iheartjane.com Jane Technologies LinkedIn: https://www.linkedin.com/company/jane-technologies-inc Jane Technologies Instagram: https://www.instagram.com/_iheartjane Jane Technologies Facebook: https://www.facebook.com/iheartjanecom Socrates Rosenfeld LinkedIn: https://www.linkedin.com/in/socratesrosenfeld   Show Credits: This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @KCSAPodcastLabs Instagram: @KCSAPodcastLabs LinkedIn: linkedin.com/company/thegreenrushpodcast

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Anne Donohoe and Phil Carlson talk to Reason Foundation's Senior Policy Analyst Michelle Minton and Research Director Geoffrey Lawrence. Michelle and Geoff join us to discuss their drug policy work at Reason Foundation, their latest projects at the organization and their respective journeys to Reason. In this episode, Michelle and Geoff share insight surrounding their recent policy briefs, the significance of interstate cannabis and “The Drug Legalization Handbook,” as well as perspective on the next big steps towards the integration of psychedelics into the US healthcare system. If you are interested in learning more about Michelle, Geoff and their work with Reason Foundation, visit the links in our show notes. Also, be sure to follow Reason, Michelle and Geoff on X. So, sit back and enjoy our conversation with Michelle Minton, Senior Policy Analyst and Geoffrey Lawrence, Research Director at Reason Foundation. Links, mentions, and socials: Reason Foundation: https://reason.org Reason Foundation drug policy work: https://reason.org/topics/drug-policy Drug Legalization Handbook: https://reason.org/policy-study/the-drug-legalization-handbook “The implications of federal cannabis rescheduling” “The case for interstate marijuana commerce right now” “The stereotype of the lazy, lefty marijuana smoker doesn't reflect reality” “Psychedelics Archives” Psychedelic Alpha: “Ibogaine Advocates Seek Ohio Opioid Settlement Funds Following Failure in Kentucky” Reason Foundation's X: https://twitter.com/ReasonFdn Michelle Minton's X: https://twitter.com/michelleminton Geoffrey Lawrence's X: https://twitter.com/GLawNV   Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Lewis Goldberg and Anne Donohoe talk to Keith Gilmore, President of the Portland Psychedelic Society (PPS), an Oregon nonprofit organization established to raise awareness about psychedelic science by funding and coordinating educational events. Keith joins us to discuss Portland's progress since Measure 109 and how the city is a leading example of community building in the psychedelic space. In this episode, Keith shares with our hosts his experience as the president of PPS and highlights the organization's cornerstone to foster education and establish safe spaces for learning and enlightenment for providers, practitioners and patients alike.  If you are interested in learning more about Keith and his work with Portland Psychedelic Society, visit the links in our show notes. Also, be sure to follow PPS and Keith on top social media platforms. So, sit back and enjoy our conversation with Keith Gilmore, President of Portland Psychedelic Society. Links, mentions, and socials: Portland Psychedelic Society: https://www.portlandpsychedelic.org Portland Psychedelic Society X: https://twitter.com/pdxpsychedelic Portland Psychedelic Society Instagram: https://www.instagram.com/portlandpsychedelic Keith Gilmore: https://keithgilmore.com Keith Gilmore Instagram: https://www.instagram.com/keithgilmoredotcom Keith Gilmore LinkedIn: https://www.linkedin.com/in/keithgilmore Keith Gilmore YouTube: http://www.youtube.com/@keith_gilmore   Show Credits: This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Phil Carlson and Anne Donohoe talk to Rebecca Martinez, Founder and Executive Director of Alma Institute. Rebecca joins us to discuss the key moments and influences that brought her from regenerative farming to drug policy, to the founding of Alma Institute, a nonprofit psychedelic training and education facility located in Portland Oregon. In this episode, our hosts learn more about Alma's Psychedelic Facilitator Certificate Program, which is open to participants from across the US, Rebecca's book, “Whole Medicine,” and the formation of Oregon's Measure 109's psilocybin services framework.  If you are interested in learning more about Rebecca and her work with Alma Institute, visit the links in our show notes. Also, be sure to follow Alma and Rebecca on LinkedIn and Instagram. So, sit back and enjoy our conversation with Rebecca Martinez, Founder and Executive Director of Alma Institute. Links, mentions, and socials: Alma Institute: https://www.almatraining.org Donate to Alma Institute: https://www.almatraining.org/donate Alma Institute Psychedelic Facilitator Certificate Program: https://www.almatraining.org/programoverview Alma Institute Newsletter Sign-up: https://www.almatraining.org/email-signup Alma Institute LinkedIn: https://www.linkedin.com/company/alma-institute-non-profit Alma Institute Instagram: https://www.instagram.com/almainstitute “Whole Medicine: A Guide to Ethics and Harm-Reduction for Psychedelic Therapy and Plant Medicine Communities” Rebecca Martinez LinkedIn: https://www.linkedin.com/in/rebecca-martinez-396ab622b Rebecca Martinez Instagram: https://www.instagram.com/rebeccamartinezwrites   Show Credits: This episode was hosted by Phil Carlson and Anne Donohoe of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Anne Donohoe and Nick Opich talk to Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel neuroplastogen therapeutics for the treatment of neuropsychiatric disorders. Dr. Tucker joins us to discuss the latest news and milestones for the company, including the selection of EB-003 as its lead candidate in its EVM 301 series, plus advice to the retail investor audience on continuing drug discovery investments in the psych space. In this episode, Joe and our hosts also discuss psychedelic companies that are leveraging AI and how Enveric's proprietary AI technology PsyAI™ integrates into the biotech's research processes. If you are interested in learning more about Joe and Enveric, visit the links in our show notes. Also, be sure to follow Enveric Biosciences on LinkedIn and X. So, sit back and enjoy our conversation with Dr. Joseph Tucker, CEO of Enveric Biosciences (NASDAQ: ENVB). Links, mentions, and socials: Enveric Biosciences: https://www.enveric.com “30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond - Enveric Biosciences (NASDAQ:ENVB), Cybin (AMEX:CYBN) - Benzinga” Enveric Biosciences LinkedIn: https://www.linkedin.com/company/EnvericBio Enveric Biosciences X: https://twitter.com/Enveric_bio   Show Credits: This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Anne Donohoe and Nick Opich talk to Wendy Bronfein, Curio Wellness Co-Founder, Chief Brand Officer and Director of Public Policy, and Rebecca Raphael, Curio's Chief Revenue Officer. Wendy and Rebecca join us to discuss their journey to starting a family cannabis business, the current state of the cannabis industry in the Maryland market, and how Curio Wellness sets itself apart from competitors. In this episode, Wendy and Rebecca also share plans to expand Curio's footprint in Mississippi through the company's franchise program, as well as their unique insights in the potential re/descheduling of cannabis and industry forecast for the rest of the year. If you are interested in learning more about Wendy, Rebecca and their work with Curio Wellness, visit the links in our show notes. Also, be sure to follow Curio, Wendy and Rebecca on LinkedIn and other top social media platforms. So, sit back and enjoy our conversation with Curio Wellness' Co-Founder, Chief Brand Officer and Director of Public Policy, Wendy Bronfein, and Chief Revenue Officer, Rebecca Raphael. Links, mentions, and socials: Curio Wellness: https://curiowellness.com Curio Wellness Careers: https://curiowellness.com/careers Curio Wellness LinkedIn: https://www.linkedin.com/company/curio-wellness Curio Wellness X: https://twitter.com/curiowellness Curio Wellness Instagram: https://www.instagram.com/curiowellnessbrand/ Wendy Bronfein LinkedIn: https://www.linkedin.com/in/wbronfein Rebecca Raphael LinkedIn: https://www.linkedin.com/in/rebecca-bronfein-raphael-448b9646   Show Credits: This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Anne Donohoe and Nick Opich talk to Eric Offenberger, CEO of Vext Science (CSE:VEXT; OTCQX:VEXTF). Eric joins us this week to discuss the company's operations and growth since his last time on the pod in February 2023, specifically the Arizona cannabis market and how Vext is navigating the unique challenges and leading the local market in retail traffic and sales. In this episode, Eric also shares insights about Ohio's road to adult-use legalization, Vext's plans for growth in the state, and what he predicts for the local market over the next year. If you are interested in learning more about Eric and Vext Science, visit the links in our show notes. Also, be sure to follow Vext Science and Eric on LinkedIn to stay up to date on the company's latest milestones. So, sit back and enjoy our conversation with Eric Offenberger, CEO of Vext Science. Links, mentions, and socials: Vext Science: https://www.vextscience.com Vext Science X: https://twitter.com/Vext_Science    Vext Science LinkedIn: https://www.linkedin.com/company/vapen-ltd Eric Offenberger LinkedIn: https://www.linkedin.com/in/erincoffenbergercpa   Show Credits: This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Anne Donohoe and Nick Opich talk to Retired United States Air Force Captain Kimberly Juroviesky, President of Ketamine Taskforce. Kimberly joins us to discuss her military service experience and how it led her to advocating for Veterans and ultimately, the Ketamine TaskForce. Kimberly and the team at Ketamine TaskForce are all volunteers working to increase accessibility to safe care, education, and insurance coverage for all humans in need, including Veterans, first responders and more. In this discussion, Kimberly shares common concerns and misconceptions among Veterans who are new to therapeutic Ketamine treatments, and tells us about her newest project, Healing Our Heroes Foundation.  If you are interested in learning more about Ketamine TaskForce or the projects that Kimberley is involved with, visit the links in our show notes. Also, be sure to follow Ketamine TaskForce on LinkedIn and check out the website for ways to get involved. So, sit back and enjoy our conversation with Kimberly Juroviesky, Retired United States Air Force Captain and President of Ketamine Taskforce. Links, mentions, and socials: Ketamine TaskForce: https://www.ketaminetaskforce.org/ Six-part docuseries: https://givebutter.com/theforgottenveteran Facebook Group: Keta-mine Infusions for Patient Health: https://www.facebook.com/groups/781893918621316 “Ketamine Infusions: A Patient Guide:” https://www.amazon.com/Ketamine-Infusions-Patients-Everything-Before/dp/B086CB14HP “KETAMINE JOURNEYS: An Integration Journal for Your Ketamine Experiences:” https://www.amazon.com/KETAMINE-JOURNEYS-Integration-Ketamine-Experiences/dp/B09TMSBM4Y/ref=sr_1_1?crid=340BO956OMY9D&keywords=ketamine+journey&qid=1648574686&sprefix=Ketamine+j%2Caps%2C108&sr=8-1 Healing Our Heroes Foundation: https://www.healingourheroesflorida.org/ Ketamine TaskForce LinkedIn: https://www.linkedin.com/in/ketamine-taskforce-inc-3b12a3201   Show Credits: This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Nick Opich and Anne Donohoe talk to Bill Panagiotakopoulos, CEO and Founder of Safe Supply Streaming Corporation (CSE:SPLY). Bill and the Safe Supply team are focused on investing in and incubating companies at the forefront of the third wave of drug policy reform. As jurisdictions around the world move to decriminalize, regulate and legalize drugs, Safe Supply is investing in the infrastructure necessary to support the transition.  In this episode, our hosts sat down with Bill to get a run down on how Safe Supply loans to help bring a responsible end to the War on Drugs, some of the biggest misconceptions people can have about drugs and why he believes that now is an ideal time to deploy meaningful capital into drug reform.  If you are interested in learning more about Bill and Safe Supply, visit the links in our show notes. Also, be sure to follow Safe Supply and Bill on LinkedIn and other top social media platforms. So, sit back and enjoy our conversation with Bill Panagiotakopoulos, CEO and Founder of Safe Supply Streaming Corporation. Links, mentions, and socials: Safe Supply Streaming Corporation: safesupply.com Safe Supply Streaming Corporation LinkedIn: https://www.linkedin.com/company/safe-supply-streaming-corp/ Safe Supply Streaming Corporation X: https://twitter.com/safesupplycorp Safe Supply Streaming Corporation Instagram: https://www.instagram.com/safesupplystreaming/ Bill Panagiotakopoulos LinkedIn: https://ca.linkedin.com/in/bill-panagiotakopoulos-67162335 Bill Panagiotakopoulos X: https://twitter.com/BillPanagiotako   Show Credits: This episode was hosted by Nick Opich and Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  Today we are back with another special hostful episode, a conversation between Lewis Goldberg, KCSA Partner; Phil Carlson, KCSA Managing Director, investor relations; and Kris Krane, KCSA's Director of Cannabis Development. In this episode, our trio convenes to discuss the recently published U.S. Department of Health and Human Services documents, which recommend to the Drug Enforcement Agency that Cannabis be rescheduled to schedule III. Listen to our hosts discuss how this will affect the legal cannabis market in the United States, possible implications for cannabis companies, and what the process looks like to move Cannabis from schedule I to schedule III. If you are interested in learning more about the latest cannabis news, visit the links in our show notes. Also, be sure to follow us on top social media platforms. So, sit back and enjoy our conversation about the latest news in the cannabis world with Lewis Goldberg, Phil Carlson and Kris Krane of KCSA Strategic Communications. Links, mentions, and socials: Green Rush Podcast: greenrushpodcast.com/ Biden Administration Calls on DEA to Move Marijuana to Schedule 3 Federal Scientists Recommend Easing Restrictions on Marijuana Release of Unredacted Rescheduling Letter Reignites Optimism in Cannabis Industry Green Rush X: @The_GreenRush Green Rush Instagram: @thegreenrush_podcast Green Rush LinkedIn: linkedin.com/company/thegreenrushpodcast   Show Credits: This episode was hosted by Lewis Goldberg, Phil Carlson and Kris Krane of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Nick Opich are back for a new episode with special guest Janet Qi, Co-Founder and CEO of PurMinds NeuroPharma. As our first recorded episode in 2024, Janet joins us this week to discuss her interesting career path which led her to PurMinds, a neuroscience company working with psychedelic compounds to treat neurological disorders. In this episode, Janet shares more about the specific indications that PurMinds is targeting, like ALS, Parkinson's and Traumatic Brain Injury; the company's unique approach to developing these drugs; and highlights on what investors need to know for PurMind's upcoming $10M Series A raise. If you are interested in learning more about Janet and PurMinds NeuroPharma, visit the links in our show notes. Also, be sure to follow PurMinds and Janet on LinkedIn and other top social media platforms. So, sit back and enjoy our conversation with Janet Qi of PurMinds NeuroPharma. Links, mentions, and socials: PurMinds NeuroPharma: purminds.com PurMinds NeuroPharma LinkedIn: linkedin.com/company/72375015    PurMinds X: twitter.com/PurMinds   PurMinds Instagram: instagram.com/purminds   Janet Qi LinkedIn: linkedin.com/in/janet-qi-b3ba9675      Show Credits: This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Nick Opich are back for a new episode with special guest Janet Qi, Co-Founder and CEO of PurMinds NeuroPharma. As our first recorded episode in 2024, Janet joins us this week to discuss her interesting career path which led her to PurMinds, a neuroscience company working with psychedelic compounds to treat neurological disorders. In this episode, Janet shares more about the specific indications that PurMinds is targeting, like ALS, Parkinson's and Traumatic Brain Injury; the company's unique approach to developing these drugs; and highlights on what investors need to know for PurMind's upcoming $10M Series A raise. If you are interested in learning more about Janet and PurMinds NeuroPharma, visit the links in our show notes. Also, be sure to follow PurMinds and Janet on LinkedIn and other top social media platforms. So, sit back and enjoy our conversation with Janet Qi of PurMinds NeuroPharma. Links, mentions, and socials: PurMinds NeuroPharma: purminds.com PurMinds NeuroPharma LinkedIn: linkedin.com/company/72375015    PurMinds X: twitter.com/PurMinds   PurMinds Instagram: instagram.com/purminds   Janet Qi LinkedIn: linkedin.com/in/janet-qi-b3ba9675      Show Credits: This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Nick Opich and Anne Donohoe are back to kick off 2024 with our last recording of 2023. Special guest Dr. Hans Eriksson, Chief Medical Officer for HMNC Brain Health, joins us this week to ring in the New Year, discussing his role at HMNC, the company's research and development efforts to identify and bring to market treatments for mental health disorders, and the latest news and progress on the psychedelics movement. In this episode, Hans also discusses the death of the beloved actor Matthew Perry, his ketamine use and how the news was presented by the media, and the risks associated with the treatment. If you are interested in learning more about Hans or to check out the latest updates from HMNC Brain Health, visit the links in our show notes. Also, be sure to follow HMNC and Hans on LinkedIn. So, sit back and enjoy our conversation with Dr. Hans Eriksson of HMNC Brain Health. Links, mentions, and socials: HMNC Brain Health: hmnc-brainhealth.com HMNC Brain Health LinkedIn: de.linkedin.com/company/hmnc-brain-health Dr. Hans Eriksson LinkedIn: linkedin.com/in/hansaeriksson   Show Credits: This episode was hosted by Nick Opich and Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: linkedin.com/company/thegreenrushpodcast Facebook: facebook.com/TheGreenRushPodcast  YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Lewis Goldberg, Anne Donohoe, Nick Opich and Kris Krane sit down for an internal hostful conversation as we reflect on 2023 and the evolution of the cannabis and psychedelic spaces. Our four hosts also discuss what they felt were the biggest moments in cannabis and psychedelics in the last year, their thoughts on the potential for rescheduling of cannabis in 2024 and what stories they want to see get more attention in 2024. For our new followers or ICYMI, check out our refreshed GreenRushPodcast.net website. Revitalized with style, enjoy the ease of locating your favorite episodes from the past and sign up for our Green Rush newsletter, brought back to keep you updated on the latest from the KCSA Green Rush team.  So, sit back and enjoy our end-of-year hostful episode featuring Lewis Goldberg, Anne Donohoe, Nick Opich and Kris Krane of the Green Rush.  Links, mentions, and socials: The Green Rush Podcast: https://greenrushpodcast.net/  Show Credits: This episode was hosted by Lewis Goldberg, Anne Donohoe, Nick Opich and Kris Krane of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: Twitter (formerly X): @The_GreenRush  Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/  Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week we are revisiting a conversation our hosts Anne Donohoe and Phil Carlson had earlier this year with Len May, CEO and Co-Founder of Endocanna Health. In that conversation, Len shared how his childhood ADD diagnosis led him to cannabis, then dispensary real estate, and on to launching Endocanna Health. He also covers his company's DNA test, how they create personalized cannabinoid recommendations, and what's next for the company and cannabis as a therapeutic. If you are interested in learning more about Endocanna Health and its testing to deliver personalized guidebooks to the endocannabinoid system, visit the links in our show notes. Also, be sure to follow Len and Endocanna Health on LinkedIn and other top social media platforms. So, sit back and enjoy our conversation with Len May of Endocanna Health.  Links, mentions, and socials: Endocanna Health: https://www.endocannahealth.com/  EndoDNA: https://endodna.com/ EndoDNA Products: https://endodna.com/products/  2023 CannMed Innovation and Investment Summit: May 15-17, 2023: https://www.cannabissciencetech.com/view/2023-cannmed-innovation-and-investment-summit-may-15-17 Endocanna Health LinkedIn: https://www.linkedin.com/company/endocanna-health Endocanna Health X (formerly Twitter): https://twitter.com/EndocannaH Endocanna Health Instagram: https://www.instagram.com/endo.dna/ Len May LinkedIn: https://www.linkedin.com/in/lenmay Len May X (formerly Twitter): https://twitter.com/LenMayDNA Len May Instagram: https://www.instagram.com/lenmaydna/   Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X (formerly Twitter): @The_GreenRush  Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/  Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Lewis Goldberg are back for a new episode with special guest Morgan Paxhia, Co-founder of Poseidon Investment Management. Morgan joins us this week to celebrate Poseidon Investment Management's 10-year anniversary, detailing the path that led to its founding, sharing some of his favorite accomplishments and plans for the future, as well as his insights and predictions on cannabis rescheduling, the federal banking movement, and investment cycles and opportunities in cannabis. In this episode, Morgan also outlines Poseidon's involvement with the David Boies lawsuit in Massachusetts, helping to explain what it means for the cannabis industry and how it could affect the industry as a whole. If you are interested in learning more about Morgan and his work with Poseidon, visit the links in our show notes. Also, be sure to follow Poseidon and Morgan on top social media platforms. So, sit back and enjoy our conversation with Morgan Paxhia of Poseidon Investment Management. Links, mentions, and socials: Poseidon Investment Management LinkedIn: https://www.linkedin.com/company/poseidon-asset-management-llc-/ Poseidon Investment Management X (formerly Twitter): https://twitter.com/PoseidonInvest Morgan Paxhia LinkedIn: https://www.linkedin.com/in/morganpaxhia/ Morgan Paxhia X (formerly Twitter): https://twitter.com/MorganPaxhia   Show Credits: This episode was hosted by Anne Donohoe and Lewis Goldberg of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X (formerly Twitter): @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Lewis Goldberg and Anne Donohoe are back for a new episode with special guest Ken Jordan, CEO, Co-Founder and Editorial Director of Lucid News. Ken joins us this week to discuss the trajectory of psychedelic mainstreaming and how it's still affected by the legacy of the Sixties counterculture, plus his experience with plant medicine and how it led to the founding of Lucid News. In this episode, Ken also emphasizes the importance of education and talks about Lucid's Psychedelic U Beta, which publishes clear, fact checked articles reviewed by top experts and serves as a starting point for those new to psychedelics as well as experienced psychonauts. If you are interested in learning more about Ken and Lucid News, visit the links in our show notes. Also, be sure to follow Ken and Lucid on top social media platforms. So, sit back and enjoy our conversation with Ken Jordan of Lucid News. Links, mentions, and socials: Lucid News: https://www.lucid.news/ Lucid News Patreon: https://www.patreon.com/lucidnews Psychedelic U Beta: https://www.lucid.news/psychedelic-u/ “After 260 Killed at Psychedelic-Trance Festival in Israel, Trauma Healing for Survivors Underway:” https://www.lucid.news/after-260-killed-at-psychedelic-trance-festival-in-israel-trauma-healing-for-survivors-underway/ “An Ambitious Vision Drives Kentucky's Ibogaine Plan to Treat Opioid Dependency:” https://www.lucid.news/an-ambitious-vision-drives-kentuckys-ibogaine-plan-to-treat-opioid-dependency/ The Alchemist's Kitchen: https://www.thealchemistskitchen.com/ Lucid News LinkedIn: https://www.linkedin.com/company/lucid-news-inc/ Lucid News X (formerly Twitter): https://twitter.com/lucidnewssite Lucid News Instagram: https://instagram.com/lucidnewspsychedelics Lucid News YouTube: https://youtube.com/channel/UCrWIoY81z5tylXkJ0-lRz-Q Lucid News Facebook: https://facebook.com/lucidnewspsychedelics Ken Jordan LinkedIn: https://linkedin.com/in/ken-jordan-24b3 Ken Jordan X (formerly Twitter): https://twitter.com/KenJ_Bklyn   Show Credits: This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X (formerly Twitter): @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Emmaline Lewis are back for a new episode with special guest Dr. Dennis McKenna, Ethnopharmacologist and the Director and President of the McKenna Academy of Natural Philosophy. Dennis joins us this week to discuss his work with the Heffter Research Group and latest projects at the McKenna Academy, including his BioGnosis project in Peru which won “Best Transpersonal Documentary” at the 2023 Psychedelic Film and Music Festival in New York City. In this episode Dennis shares his insight on the challenges ahead surrounding patient access to psychedelic-assisted therapies, as well as the importance of honoring indigenous knowledge and practices throughout the process of integrating these emerging therapies into the U.S. healthcare system. If you are interested in learning more about Dennis and the McKenna Academy of Natural Philosophy, visit the links in our show notes. Also, be sure to follow Dennis on LinkedIn and check out his new podcast series, Brainforest Café. So, sit back and enjoy our conversation with Dr. Dennis McKenna of the McKenna Academy of Natural Philosophy. Links, mentions, and socials: McKenna Academy of Natural Philosophy: https://mckenna.academy/ Heffter Research Group: https://www.heffter.org/ Donate to McKenna Academy of Natural Philosophy: https://mckenna.academy/donate/ BioGnosis: https://mckenna.academy/mka-programs/biognosis/ BioGnosis: Bridges to Ancestral Wisdom trailer: https://vimeo.com/710890317 ESPD Educational Courses: https://mckenna.academy/mka-programs/espd/ ESPD50: https://mckenna.academy/mka-programs/espd50/ ESPD55: https://mckenna.academy/mka-programs/espd55/ Brotherhood of the Screaming Abyss: My Life with Terence McKenna: https://synergeticpress.com/catalog/brotherhood-of-the-screaming-abyss-my-life-with-terence-mckenna/ Brainforest Café Podcast: https://mckenna.academy/mka-podcast/ Dennis McKenna LinkedIn: https://linkedin.com/in/dennis-mckenna-5931aa1a/ ICEERS Ayahuasca Defense Fund: https://www.iceers.org/adf/ Indigenous Medicine Conservation Fund: https://imc.fund/   Show Credits: This episode was hosted by Anne Donohoe and Emmaline Lewis of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X (formerly Twitter): @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Anne Donohoe and Nick Opich are back for a new episode with special guest Jess Tyler, Chief Revenue and Experience Officer at MJBiz and MJBizCon. Jess joins us this week to discuss what brought her into the cannabis industry and the work that goes into producing the Marijuana Business Conference, the #1 global cannabis business conference and trade show. Held each year at the Las Vegas Convention Center, the 12th-annual MJBizCon will showcase thousands of exhibitors over 3 days complete with pre-show forums and hundreds of industry speakers. In this conversation, Jess expands upon what to expect at this year's MJBizCon, including the show's post-COVID evolution, new installments, and the speakers she's most excited for, as well as MJBiz's strategic partnership with re:Mind to produce the Second Annual Psychedelic Business Forum on November 28th and 29th. If you are interested in learning more about Jess, MJBiz and MJBizCon or the 2023 Psychedelic Business Forum, visit the links in our show notes. Also, be sure to follow Jess and MJBiz on LinkedIn and other top social media platforms. So, sit back and enjoy our conversation with Jess Tyler of MJBizCon. Links, mentions, and socials: MJBiz: https://mjbiz.com/ MJBizCon: https://mjbizconference.com/ MJBizDaily: https://mjbizdaily.com/ 2023 Psychedelics Business Forum: https://remindmedia.com/2023-business-forum/ MJBiz LinkedIn: https://www.linkedin.com/company/mjbiz/ MJBiz X (formerly Twitter): https://www.twitter.com/MJBizDaily MJBizDaily Instagram: https://www.instagram.com/mjbizdaily/?hl=en Jess Tyler LinkedIn: https://www.linkedin.com/in/jess-tyler-cem   Show Credits: This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X (formerly Twitter): @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Nick Opich and Lewis Goldberg are back for a new episode with special guest Brigadier General (Ret.) Stephen N. Xenakis, MD, Executive Director of the American Psychedelic Practitioners Association (APPA). Steve joins us this week to discuss what led him to the military and psychiatry and what it was like taking this path while his peers explored drugs and the counterculture movement, as well as his work with APPA and its publishing of the first professional practice guidelines for psychedelic-assisted therapy practitioners. In this conversation, Steve also helps us to better understand our veteran and military men and women's behavioral health needs and how his psychiatric and military expertise uniquely primed him to help APPA in its mission to safely integrate psychedelics into the U.S. healthcare system. If you are interested in learning more about Steve and the work he's leading with the team at APPA, visit the links in our show notes. Also, be sure to follow Steve and APPA on LinkedIn and other top social media platforms. So, sit back and enjoy our conversation with General Xenakis of the American Psychedelic Practitioners Association. Links, mentions, and socials: American Psychedelic Practitioners Association: https://www.appa-us.org/ Donate to APPA: https://creative-visions.networkforgood.com/projects/196482-american-psychedelic-practitioners-association-appa Professional Practice Guidelines for Psychedelic-Assisted Therapy Practitioners: https://www.appa-us.org/standards-and-guidelines  APPA LinkedIn: https://www.linkedin.com/company/american-psychedelic-practitioners-association/ APPA X (formerly Twitter): https://www.twitter.com/apsychedelicpa/ APPA Instagram: https://www.instagram.com/apsychedelicpa/ General Xenakis LinkedIn: http://linkedin.com/in/stephen-xenakis-5b950312/   Show Credits: This episode was hosted by Nick Opich and Lewis Goldeberg of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: X (formerly Twitter): @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true